(February 7, 2023) The Reagan-Udall Foundation for the FDA (FDA Foundation) has announced new officers and members of its Board of Directors. 

Richard L. Schilsky, MD, FACP, FSCT, FASCO, has been elected to a three-year term as Chair of the FDA Foundation Board of Directors. Georges C. Benjamin, MD, assumes the role of Vice Chair. Allan Coukell, BScPharm, continues his service as Secretary/Treasurer. 

 Three new members have been appointed to the FDA Foundation Board for a four-year term: 

The Food and Drug Administration will create a senior position to oversee food safety and nutrition after a series of foodborne-illness crises, including a nationwide baby formula shortage, exposed major flaws in the agency’s structure and culture, The Post’s Jacob Bogage reports.

The head of the US Food and Drug Administration proposed sweeping changes to the agency’s food safety programs Tuesday in order to protect the US food supply and promote better nutrition.

Read more

In July, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Human Foods Program, including the Office of Food Policy and Response (OFPR), the Center for Food Safety and Applied Nutrition (CFSAN), as well as relevant parts of the Office of Regulatory Affairs (ORA).

Earlier this year, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Tobacco Program, to be conducted by an external expert panel facilitated by the Reagan-Udall Foundation, led by former FDA Chief of Staff Lauren Silvis. The panel was asked to assess the Tobacco Program’s regulatory processes and agency operations relating to regulations and guidance, application review, compliance and enforcement and communication with the public and other stakeholders.

Last month, the Reagan-Udall Foundation delivered a damning review of the Food and Drug Administration’s (FDA) performance as a tobacco regulator.  

Read more